BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 37955787)

  • 1. Molecular insight into renal cancer and latest therapeutic approaches to tackle it: an updated review.
    Murali R; Gopalakrishnan AV
    Med Oncol; 2023 Nov; 40(12):355. PubMed ID: 37955787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular-based therapies for renal cell carcinoma.
    Zisman A; Pantuck AJ; Belldegrun AS
    Curr Urol Rep; 2001 Feb; 2(1):55-61. PubMed ID: 12084296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in the treatment of renal cell carcinoma.
    Dutcher JP
    Ther Adv Urol; 2013 Dec; 5(6):338-53. PubMed ID: 24294292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma: molecular biology and targeted therapy.
    Su D; Stamatakis L; Singer EA; Srinivasan R
    Curr Opin Oncol; 2014 May; 26(3):321-7. PubMed ID: 24675233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approaches in the therapy of metastatic renal cell carcinoma.
    Lam JS; Leppert JT; Belldegrun AS; Figlin RA
    World J Urol; 2005 Jul; 23(3):202-12. PubMed ID: 15812574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory Therapies for Renal Cell Carcinoma.
    Liu M; Wu H; Shangguan D; Jiang Y; Li X; Liu S; Zhou B; Yin T; Gong Z
    Protein Pept Lett; 2018; 25(6):534-547. PubMed ID: 29848257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Immunotherapy Into the Management of Renal Cell Carcinoma.
    Zibelman M; Plimack ER
    J Natl Compr Canc Netw; 2017 Jun; 15(6):841-847. PubMed ID: 28596263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successes and limitations of targeted therapies in renal cell carcinoma.
    Pracht M; Berthold D
    Prog Tumor Res; 2014; 41():98-112. PubMed ID: 24727990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
    Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; Rouprêt M
    BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses.
    Elballal MS; Sallam AM; Elesawy AE; Shahin RK; Midan HM; Elrebehy MA; Elazazy O; El-Boghdady RM; Blasy SH; Amer NM; Farid HI; Mohammed DA; Ahmed SA; Mohamed SS; Doghish AS
    Pathol Res Pract; 2023 May; 245():154439. PubMed ID: 37028108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary kidney cancer: unique opportunity for disease-based therapy.
    Linehan WM; Pinto PA; Bratslavsky G; Pfaffenroth E; Merino M; Vocke CD; Toro JR; Bottaro D; Neckers L; Schmidt LS; Srinivasan R
    Cancer; 2009 May; 115(10 Suppl):2252-61. PubMed ID: 19402075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in renal cell carcinoma.
    D'Avella C; Abbosh P; Pal SK; Geynisman DM
    Urol Oncol; 2020 Oct; 38(10):763-773. PubMed ID: 30478013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions.
    Lalani AA; McGregor BA; Albiges L; Choueiri TK; Motzer R; Powles T; Wood C; Bex A
    Eur Urol; 2019 Jan; 75(1):100-110. PubMed ID: 30327274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Game of thrones: immunotherapy versus molecular targeted therapy in renal cell cancer scenarios.
    Cetin B; Kosar A
    Int Urol Nephrol; 2019 Dec; 51(12):2107-2117. PubMed ID: 31468288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Biomarkers and Novel Targets in the Treatment of Metastatic Renal Cell Carcinoma.
    Zhang H; Zhu G
    Curr Med Chem; 2021; 28(25):5213-5227. PubMed ID: 33357191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential New Therapeutic Approaches for Renal Cell Carcinoma.
    Yang DC; Chen CH
    Semin Nephrol; 2020 Jan; 40(1):86-97. PubMed ID: 32130970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and Management of Hereditary Renal Cell Cancer.
    Menko FH; Maher ER
    Recent Results Cancer Res; 2016; 205():85-104. PubMed ID: 27075350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.